Robotic Replacement of the Descending Thoracic Aorta: An Alternative to Endovascular Therapy?

Author(s):  
Eyal E. Porat ◽  
Peter D. Herrera ◽  
Roy Sheinbaum ◽  
Anthony L. Estrera ◽  
Tam T.T. Huynh ◽  
...  

Background Replacement of the descending thoracic aorta is traditionally performed via a left thoracotomy. Endovascular treatment of descending thoracic aortic aneurysms has recently evolved as an alternative treatment for selected patients, yet no long-term results are available. The authors replaced the descending thoracic aorta in a group of pigs with an interposition Dacron graft using a closed-chest, totally robotic technique. Methods Ten pigs, weighing 25 to 45 kg, underwent surgery using the DaVinci robotic surgical system. Under single-lung ventilation and CO2 insufflation, the descending thoracic aorta was completely mobilized. Proximal and distal cross-clamps were applied through separate accessory stab wounds. The mid-descending thoracic aorta was excised. An interposition Dacron graft was robotically sewn in an end-to-end fashion to the descending thoracic aorta using interrupted nitinol clips. Results All animals survived the procedure. Mean aortic clamp time was 55 ± 14 minutes. All anastomoses were completed without difficulty with a mean total anastomotic time of 42 ± 11 minutes. The anastomoses were challenged for bleeding by administrating α1-adrenergic receptor agonists to a systolic blood pressure of 200 mm Hg with no evidence of leak. Discussion Robotic replacement of the thoracic aorta is feasible and reproducible. This procedure provides the standard Dacron graft repair with its known long-term results. The added value of robotic technology to the therapeutic armamentarium in the treatment of thoracic aortic aneurysms may be worth the effort required for procedural development. Furthermore, it may serve as a valid alternative to endovascular treatment of thoracic aortic aneurysms.

Vascular ◽  
2011 ◽  
Vol 19 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Joachim Andrassy ◽  
Rolf Weidenhagen ◽  
Georgios Meimarakis ◽  
M Rentsch ◽  
K-W Jauch ◽  
...  

Multiple reports could show a reduced risk for thoracic endovascular aortic repair (TEVAR) compared with open treatment. The aim of this study was to evaluate our twelve-year TEVAR experience for thoracic aortic aneurysms and compare these results with open repair. All patients who had received either open or endovascular surgery for a degenerative aortic aneurysm of the descending thoracic aorta in our center were evaluated retrospectively. N = 53 TEVAR patients (1997–2008) were included and their course was compared with an open-surgery group of n = 24 patients (1992–2002). The percentage of symptomatic patients was 43% (TEVAR) and 42% (open surgery). Endovascular treatment resulted in a significantly reduced 30-day (5.7% versus 25% P = 0.02) and one-year mortality (19% versus 42% P = 0.05) in the entire cohort. Symptomatic patients benefited the most from TEVAR (30-day mortality: 9% versus 40%, P = 0.06; one-year mortality: 27% versus 70%, P = 0.049) whereas the survival of our asymptomatic patients was not significantly different (30-day mortality: 3% versus 14%, P = 0.22; one-year mortality: 13% versus 21%, P = 0.65). Lastly, Kaplan–Meier analysis showed a significantly improved survival after TEVAR ( P = 0.05) and in particular for the symptomatic patients ( P = 0.003). In conclusion, endovascular treatment for patients with degenerative thoracic aortic aneurysms has significant advantages over open surgery.


2014 ◽  
Vol 29 (3) ◽  
pp. 353-358 ◽  
Author(s):  
Spiridon Botsios ◽  
Johannes Frömke ◽  
Gerhard Walterbusch ◽  
Karl Schuermann ◽  
Jan Reinstadler ◽  
...  

2014 ◽  
Vol 28 (6) ◽  
pp. 1371
Author(s):  
Aurélien Felisaz ◽  
Olivier Coffin ◽  
Djelloul Gouicem ◽  
Laura Palcau ◽  
Elise Mackowiak ◽  
...  

2018 ◽  
Vol 67 (2) ◽  
pp. 363-368 ◽  
Author(s):  
David N. Ranney ◽  
Morgan L. Cox ◽  
Babatunde A. Yerokun ◽  
Ehsan Benrashid ◽  
Richard L. McCann ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Luigi Irace ◽  
Antonella Laurito ◽  
Salvatore Venosi ◽  
Francesco Giosuè Irace ◽  
Alban Malay ◽  
...  

Study Aim. Evaluation of results in blunt injury of the thoracic aorta (BAI) endovascular treatment.Materials and Methods. Sixteen patients were treated for BAI. Thirteen patients had associated polytrauma, 4 of these had a serious hypotensive status and 4 had an hemothorax. In the remaining 3, two had a post-traumatic false aneurysm of the isthmus and 1 had a segmental dissection. In those 13 patients a periaortic hematoma was associated to hemothorax in 4. All patients were submitted to an endovascular treatment, in two cases the subclavian artery ostium was intentionally covered.Results. One patient died for disseminated intravascular coagulation. No paraplegia was recorded. No ischemic complications were observed. A type I endoleak was treated by an adjunctive cuff. During the followup (1–9 years) 3 patients were lost. A good patency and no endoleaks were observed in all cases. One infolding and 1 migration of the endografts were corrected by an adjunctive cuff.Conclusion. The medium and long term results of the endovascular treatment of BAI are encouraging with a low incidence rate of mortality and complications. More suitable endo-suite and endografts could be a crucial point for the further improvement of these results.


2017 ◽  
Vol 65 (1) ◽  
pp. e8-e9 ◽  
Author(s):  
David N. Ranney ◽  
Morgan L. Cox ◽  
Babatunde Yerokun ◽  
Ehsan Benrashid ◽  
Richard L. McCann ◽  
...  

2018 ◽  
Vol 27 (02) ◽  
pp. 081-091 ◽  
Author(s):  
Takao Ohki ◽  
Yuji Kanaoka ◽  
Koji Maeda

AbstractThe technologies and innovations applicable to endovascular treatment for complex aortic pathologies have progressed rapidly over the last two decades. Although the initial outcomes of an endovascular aortic repair have been excellent, as long-term data became available, complications including endoleaks, endograft migration, and endograft infection have become apparent and are of concern. Previously, the indication for endovascular therapy was restricted to descending thoracic aortic aneurysms and abdominal aortic aneurysms. However, its indication has expanded along with the improvement of techniques and devices, and currently, it has become possible to treat pararenal aortic aneurysms and Crawford type 4 thoracoabdominal aortic aneurysm (TAAA) using the off-the-shelf devices. Additionally, custom-made devices allow for the treatment of arch or more extensive TAAAs. Endovascular treatment is applied not only to aneurysms but also to acute/chronic dissections. However, long-term outcomes are still unclear. This article provides an overview of available devices and the results of endovascular treatment for various aortic pathologies.


2005 ◽  
Vol 53 (6) ◽  
pp. 295-301 ◽  
Author(s):  
Hirofumi Midorikawa ◽  
Tomohiro Ogawa ◽  
Kouichi Satou ◽  
Shunichi Hoshino ◽  
Shinya Takase ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document